Invention Grant
- Patent Title: Compositions and methods for treating CNS disorders
-
Application No.: US16961097Application Date: 2019-01-11
-
Publication No.: US11718642B2Publication Date: 2023-08-08
- Inventor: Albert Jean Robichaud , Francesco G. Salituro , Maria Jesus Blanco-Pillado , Daniel La , Boyd L. Harrison
- Applicant: Sage Therapeutics, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Sage Therapeutics, Inc.
- Current Assignee: Sage Therapeutics, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Honigman LLP
- Agent Andrew N. Weber; Jonathan P. O'Brien
- International Application: PCT/US2019/013315 2019.01.11
- International Announcement: WO2019/140272A 2019.07.18
- Date entered country: 2020-07-09
- Main IPC: A61K31/352
- IPC: A61K31/352 ; A61K31/382 ; A61K31/385 ; A61K31/39 ; A61K31/435 ; A61K31/498 ; A61K31/502 ; A61K31/517 ; A61K31/53 ; A61K31/536 ; A61K31/415 ; C07D221/08 ; C07D237/26 ; C07D239/70 ; C07D241/36 ; C07D253/08 ; C07D265/02 ; C07D265/12 ; C07D265/34 ; C07D279/02 ; C07D279/08 ; C07D279/14 ; C07D291/08 ; C07D311/78 ; C07D319/02 ; C07D319/08 ; C07D319/14 ; C07D323/04 ; C07D327/06 ; C07D327/10 ; C07D335/04 ; C07D339/08 ; C07D341/00 ; C07D401/06 ; C07D405/14 ; C07D407/14 ; C07D409/14 ; C07D411/14 ; C07D413/14 ; C07D417/14 ; C07D419/14 ; C07J73/00
Abstract:
Provided herein is a compound of Formula (I-I), or a pharmaceutically acceptable salt thereof, wherein the variables are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I-I), and methods of using the compounds, e.g. in the treatment of CNS-related disorders.
Information query
